Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chief Scientific Officer acquired 48,140 shares (grant or award)
  3. 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $3.61 ($361,000)
  4. 4 Shares withheld for taxes CFO and Treasurer gave up 1,256 shares (to pay taxes)
  5. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,435 shares (to pay taxes)
  6. 4 Shares withheld for taxes CFO and Treasurer gave up 1,426 shares (to pay taxes)
  7. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,629 shares (to pay taxes)
  8. 4 Grant or award General Counsel, Secretary acquired 40,000 shares (grant or award)
  9. 4 Open-market sale CFO and Treasurer sold 36,955 shares at $8.26 ($305,248)
  10. 4 Open-market sale Director sold 19,500 shares at an average $7.83 ($152,635)
  11. 4 Other disposition 10% owner disposed of 7,024,208 shares (other)
  12. 4 Other disposition Director disposed of 7,024,208 shares (other)
  13. 4 Other acquisition Director acquired 500,182 shares (other)
  14. 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $10.00 ($200,070)
  15. 4 Other disposition Director disposed of 748,694 shares (other)
  16. 4 Other disposition 10% owner disposed of 748,694 shares (other)
  17. 4 Other acquisition Director acquired 139,912 shares (other)
  18. 4/A Grant or award Chief Medical Officer acquired 152,335 shares (grant or award)
  19. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,472 shares (to pay taxes)
  20. 4 Shares withheld for taxes CEO gave up 1,840 shares (to pay taxes)

Page 10 of 13 · 246 filings